ArticleBone marrow transplantation2026
Real-world eligibility, utilization, and barriers to CAR T-cell therapy in relapsed/refractory mantle cell lymphoma.
Robert Puckrin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it